Australia's Universal Biosensors gains on FDA nod for coagulation analyser

Universal Biosensors

19/03/2024 24:42

** Shares of Universal Biosensors  UBI.AX  rise as much as
81.3% to A$0.290, posting a record intraday percentage gain
    ** Stock hits its highest level since Oct 19, 2023
    ** The medical device maker says it received U.S. FDA
approval for its Xprecia Prime Coagulation Analyzer as a Class
II device
    ** Over 10.5 mln shares change hands, compared with the
30-day average volume of 121,396
    ** Stock down 20% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))